July 1, 2022

In the context of oncology, the use of artificial intelligence/machine learning has enabled the growth of precision medicine, helping clinicians increase efficiency and accuracy, according to Alexander S.Baras, MD, PhD.

According to study investigators, "the number of invited women panelists increased during the study period with a subsequent decrease in proportion of manels, there are topics/specialties where female representation remains stagnant."

Treatment with relacorilant showed improvement in overall survival in patients platinum-resistant or platinum-refractory ovarian cancer when combined with nab-paclitaxel.

After a meeting like the 2022 ASCO Annual Meeting, one cannot help but be reinvigorated to continue advancing cancer care and feel optimistic about the future of oncology, says John M. Burke, MD.